Myocardial Ischemia Clinical Trials

30 recruiting

Myocardial Ischemia Trials at a Glance

33 actively recruiting trials for myocardial ischemia are listed on ClinicalTrialsFinder across 6 cities in 27 countries. The largest study group is Not Applicable with 14 trials, with the heaviest enrollment activity in London, Seoul, and Barcelona. Lead sponsors running myocardial ischemia studies include Biotronik AG, Ankara City Hospital Bilkent, and AliveCor.

Browse myocardial ischemia trials by phase

Treatments under study

About Myocardial Ischemia Clinical Trials

Looking for clinical trials for Myocardial Ischemia? There are currently 30 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Myocardial Ischemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Myocardial Ischemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting

Evaluation of a Diagnostic Software for Coronary Artery Disease Using Retrospective CCTA Data (CODEX-1 Study)

AtherosclerosisMyocardial IschemiaCoronary Artery Disease
Instituto de Investigación Biomédica de Salamanca1,000 enrolled4 locationsNCT06977295
Recruiting
Not Applicable

Speed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta

Myocardial IschemiaSudden Cardiac DeathAAOCA+7 more
IRCCS Policlinico S. Donato38 enrolled1 locationNCT06705751
Recruiting
Not Applicable

Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

Heart FailureCardiovascular DiseasesMyocardial Ischemia+5 more
AliveCor1,000 enrolled4 locationsNCT06271577
Recruiting
Not Applicable

COronoary Microcirculation Analysis NETwork

Coronary Artery DiseaseEchocardiographyMicrocirculation Resistance+4 more
Medical University of Bialystok180 enrolled1 locationNCT07498231
Recruiting
Not Applicable

A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

Arterial Occlusive DiseasesCardiovascular DiseasesMyocardial Ischemia+4 more
Fundación EPIC700 enrolled13 locationsNCT07286578
Recruiting
Not Applicable

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Arterial Occlusive DiseasesCardiovascular DiseasesCoronary Disease+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS576 enrolled1 locationNCT06535568
Recruiting

Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

Cardiovascular DiseasesCoronary DiseaseMyocardial Ischemia+2 more
Jung-min Ahn2,000 enrolled23 locationsNCT05044273
Recruiting
Not Applicable

Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome

Myocardial IschemiaCoronary Artery DiseaseChronic Coronary Syndrome+1 more
Gødstrup Hospital570 enrolled1 locationNCT05865600
Recruiting

Effective Myocardial Protection Time of Del Nido Cardioplegia in Adult Cardiac Surgery

Myocardial IschemiaHeart Valve DiseasesAortic Diseases+3 more
Muhammet Talha Ceran, MD80 enrolled1 locationNCT07249424
Recruiting

Evaluation of Perioperative Myocardial Injury in Patients Undergoing Below-Knee Lower Extremity Surgery

Myocardial IschemiaDiabetes Complication
Ankara City Hospital Bilkent54 enrolled1 locationNCT07241572
Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

Myocardial IschemiaCoronary Artery DiseaseIschemic Heart Disease+3 more
Biotronik AG100 enrolled8 locationsNCT07091682
Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System

Acute Coronary SyndromeMyocardial IschemiaCoronary Artery Disease+3 more
Biotronik AG1,859 enrolled1 locationNCT05540223
Recruiting
Not Applicable

Effectiveness of Inspiratory Muscle Training for People With Ischemic Heart Disease Revascularized by Percutaneous Transluminal Coronary Angioplasty.

Myocardial IschemiaCoronary Arterial Disease (CAD)
University of Cadiz72 enrolled1 locationNCT06681740
Recruiting

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

Heart FailureCardiovascular DiseasesStroke+21 more
Herlev and Gentofte Hospital1,000 enrolled1 locationNCT04950218
Recruiting

The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery

SurgeryLung CancerArrhythmia+1 more
Tampere University Hospital100 enrolled1 locationNCT05094843
Recruiting
Phase 1

Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease

Myocardial Ischemia
University of Virginia40 enrolled1 locationNCT05762952
Recruiting

OR6A2 on Monocytes and Cardiovascular Outcomes in Myocardial Ischemia-Reperfusion Injury

Myocardial Ischemia-Reperfusion Injury
Southeast University, China200 enrolled1 locationNCT07100457
Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients

Myocardial IschemiaCoronary Artery Disease
GE Healthcare54 enrolled5 locationsNCT04604782
Recruiting
Not Applicable

Bright Light Exposure in Surgical Patients

Myocardial IschemiaEndothelial DysfunctionCritical Illness
University of Colorado, Denver70 enrolled1 locationNCT03822949
Recruiting
Not Applicable

Myocardial Perfusion Quantification With SPECT Using Multi-Pinhole Collimator Compared to Photon-Counting Coronary CTA

Cardiovascular DiseasesCoronary DiseaseMyocardial Ischemia+6 more
Semmelweis University50 enrolled1 locationNCT06670768